SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B):
January – September 2012
Global Net sales grew by 72% to SEK 110.8m (64.4). Adjusted for currency fluctuations, net sales rose by 69% Year over Year (Y-o-Y)
The worldwide number of NIOX MINO® repeat tests sold increased by 48% and for clinical use in the US grew by 68%
January – September 2012
Global Net sales grew by 72% to SEK 110.8m (64.4). Adjusted for currency fluctuations, net sales rose by 69% Year over Year (Y-o-Y)
The worldwide number of NIOX MINO® repeat tests sold increased by 48% and for clinical use in the US grew by 68%
